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Summary
The authors conducted a genetic analysis of patients with 
chronic pancreatitis in Ukraine. It turned out that more than 
a quarter of patients had mutations of PRSS1, SPINK1, 
CFTR genes. Peculiarities of combinations of ADH, ALDH, 
CYP2E1 genes, encoding enzymes involved in ethanol me-
tabolism, are revealed. Obtained data testify to the reason-
ability of continuing research in this fi eld.
Keywords: chronic pancreatitis, genetic predisposition, 
ethanol metabolism.
Резюме
Генетические мутации у больных хроническим пан-
креатитом в Украине
Авторы провели генетический анализ у больных хро-
ническим панкреатитом в Украине. Оказалось, что 
более чем у четверти больных имеют место мутации 
генов PRSS1, SPINK1, CFTR. Выявлены особенности 
комбинации генов ADH, ALDH, CYP2E1, кодирующих 
ферменты, участвующие в метаболизме этанола. По-
лученные данные свидетельствуют о целесообразности 
продолжения исследований в этом направлении.
Ключевые слова: хронический панкреатит, генетиче-
ская предрасположенность, метаболизм этанола.
Introduction
Problem of chronic pancreatitis (CP) is one of 
the most complex ones in medicine and particularly 
in gastroenterology. Frequency of CP in the world 
has doubled in the past 30 years, diagnostics and 
treatment being difficult for general practitioners. 
CP represents itself a serious medico-social problem, 
predominantly able-bodied population suffering 
from this disease while it leads to the decreasing 
quality of patients’ life, partial or full loss of working 
capacity [5].
Except main etiological factors of CP (alcohol 
abuse, biliary pathology), special attention has 
been recently paid to the genetic predisposition. 
Since active trypsin has the potential of driving the 
pancreatic digestive enzyme activation cascade, 
number of mechanisms are engaged in protection 
of the pancreas and body from autodigestion. There’s 
an occurrence of breach in the protection of acinar 
cells due to the genetic mutations [1].
It was defined less than a decade ago that the 
hereditary pancreatitis was a rare pathology of the 
pancreas, clinically characterized by recurrent episo-
des of acute pancreatitis in the form of abdominal 
pain and dyspeptic syndromes, gradually increasing 
frequency and severity of relapses, increasing degree 
of functional (exocrine and/or endocrine) pancreatic 
insufficiency, burdened familial history, high risk of 
pancreatic cancer. Now it should be admitted that 
a wide range of possible associations of geno- and 
phenotype of hereditary pancreatitis may vary from 
direct autosomal dominant traits of the disease with 
nearly complete penetrance (dominant cationic 
trypsinogen (PRSS1) gene mutation) through mild 
genetic risk factors without evidence of Mendelian 
inheritance (pancreatic secretory trypsin inhibitor 
(SPINK1), cystic fibrosis transmembrane conduc-
tance regulator (CFTR) gene mutations) to subtle 
hereditary disease modifiers that can be identifi-
ed only in complex studies (genetic mutations in 
chymotrypsin C, anionic trypsinogen (PRSS2), etc.). 
Thus, identification of mutations in different genes, 
particularly in PRSS1, PRSS2, SPINK1, keratin, etc., has 
changed the understanding of CP pathophysiology, 
to some extent having determined the significance 
of influence of environmental factors on the degree 
of penetrance of hereditary pancreatitis, severity of 
its clinical symptoms and age of onset [1, 3].
Nowadays alcohol and drug addiction are 
considered to be the most acute socially significant 
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problems. Nature of these occurrences may vary; in 
each case alcoholism and drug addiction can be the 
consequences of effect of different groups of such 
factors as social, environmental, and psychological 
ones. However, heredity, i.e. human genotype, is 
supposed to be their background, and it can stren-
gthen or weaken the effect of other factors while 
addictions’ development. Predisposing environment 
includes all the factors contributing to the manifes-
tation of relevant genetic traits [2].
It’s crucial to keep in mind that the identification 
of specific genetic variants cannot be regarded as de-
termination or confirmation of diagnosis, as well as 
cannot be used for diagnosing of various addictions, 
it being only an ancillary physician’s test, allowing to 
choose proper method of therapy [3].
Role of genetic mutations defining the enzymes 
involved in alcohol metabolism is widely discussed. 
Alcohol dehydrogenase (ADH) and aldehyde dehy-
drogenase (ALDH) are the key enzymes involved in 
ethanol metabolism. At the first stage of ADH meta-
bolism converts ethanol to acetaldehyde, then, with 
the help of ALDH enzyme, turning the acetaldehyde 
into acetate non-toxic products, CO2 and water [3].
Different populations are described to have 
different isoforms of these enzymes: active and 
inactive ones. ADH activity is determined by ami-
noacid in position 48 of protein; histidine in such 
a position is typical for the active form (ADH1B*2), 
while arginine – for inactive one (ADH1B*1). ALDH 
activity is determined by aminoacid in position 504: 
glutamine – active form (ALDH2*1), lysine – inactive 
form (ALDH2*2). Presence of allele encoding ADH 
active form (p.48His, c.143A, ADH1B*2) and/or ALDH 
inactive form (r.504Lys, c.1510A, ALDH2*2) in human 
genotype leads to increased concentrations of the 
aldehyde, causing the number of such unpleasant 
symptoms as nausea, vertigo, hyperemia of the face 
skin subjectively evaluated as “discomfort in the 
body”, etc., thus leading to the rarer alcohol intake 
and its intake in smaller quantities [1].
Therefore, presence of alleles c.143A of ADH2 
gene and c.1510A of ALDH2 gene in genotype may 
be considered as a protective factor, but it cannot 
be an obstacle for the development of alcohol ad-
diction.
Cytochrome 2E1 (CYP2E1) is involved in the me-
tabolism of acetone, benzene, carbon tetrachloride 
and other carcinogens that are present in tobacco 
smoke. Enzyme also takes part in the ethanol meta-
bolism. Variant T of RsaI (RsaI c2) polymorphism is 
characterized by increased transcriptional activity 
and is associated with alcoholic liver disease, while 
variant C of PstI (PstI+) polymorphism corresponds 
to the increased risk of oncological diseases’ develop-
ment. Variant C of DraI polymorphism is also a cancer 
marker. In Caucasian populations rate of occurrence 
of variants RsaI c2 and PstI+ makes up 1−3%, occur-
rence of variant DraI is about 10% [1].
Oxidative stress caused by ethanol seems to be 
the main mechanism of ethanol lesion of the liver. 
CYP2E1 enzyme is a producer of hydrogen peroxide 
and free peroxide and hydroxyl radicals. CYP2E1 is 
known to be induced by ethanol. Consequently, 
change of the enzymatic activity or its level in the 
tissues corresponds to the risk of lesion of different 
tissues [1, 3].
The aim of study is to analyze the frequency of 
mutations of different genes upon chronic pancre-
atitis in Ukraine.
Materials and methods 
We examined 68 patients with definite CP, 
including 52 males and 16 females aged from 17 
to 61. All the patients were diagnosed to have CP 
according to M-ANNHEIM criteria [4]. It means that 
patients had typical clinical history of CP and one or 
more of the following additional criteria: pancreatic 
calcifications, moderate or evident ductal lesions 
(according to the Cambridge classification), evident 
and persistent exocrine insufficiency defined as a 
pancreatic steatorrhea markedly reduced by enzyme 
supplementation, typical histology of an adequate 
histological specimen. M-ANNHEIM severity index 
in our patients was the following: А — 9 (13.2%), B 
— 25 (36.7%), C — 27 (39.8%), D — 5 (7.4%), E — 2 
(2.9%) patients.
According to the results of fecal elastase test by 
immune-enzyme method, 48 (70.6%) patients had 
severe, 20 (29.4%) patients had moderate and mild 
pancreatic insufficiency.
Control group included 80 healthy persons 
matched with CP patients in age, sex and alcohol 
consumption, but without CP.
 52 patients were diagnosed to have alcoholic 
CP, 15 patients had idiopathic pancreatitis, 1 patient 
– familial pancreatitis.
DNA-diagnostics was performed in the de-
partment of molecular-genetic studies at Central 
Research Laboratory on the basis of Donetsk Na-
tional Medical University. Genomic DNA, isolated 
from the leukocytes of whole blood with the use of 
reagent «DNA-express-blood» by «Lytech» (Moscow, 
Russia), was subjected to analysis for the detection 
of mutations (polymorphisms). Diagnostic test-
systems «SNP-Express» were applied in the study 
in order to detect such mutations as: mutations of 
PRSS1, SPINK1, CFTR genes; mutation of «alcoholic 
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cytochrome» CYP2E1 -1293G/C (c1/c2), ADH muta-
tion ADH1B Arg47His (ADH2*1/ADH2*2), ALDH 
mutation ALDH2 Glu487Lys (ALDH2*2) with two pairs 
of allele-specific primers. Analysis of polymorphic 
DNA-loci was conducted by means of polymerase 
chain reaction (PCR) followed by electrophoretic 
detection. Reaction was performed under the follow-
ing conditions: initial denaturation at 93°C for 1 min, 
followed by 35 cycles consisting of denaturation — 
93°C, 10 sec; annealing of the primers — 64°C, 10 sec; 
elongation — 72°C, 20 sec. PCR was performed on 
the amplifier Gene Amp® PCR System 2400 (Applied 
Biosystems). Detection of the amplified fragments 
was carried out by electrophoresis in 3% agarose 
gel stained with ethidium bromide. Visualization 
of results was conducted in the ultraviolet transil-
luminator “TFX-20.M” (“Vilber Lourmat”, France). 
Risk assessment, frequency of genotypes, alleles 
and confidence intervals were performed with the 
help of Microsoft Excel. Differences in the frequency 
of alleles and genotypes between groups were as-
sessed using χ2 criterion and calculation of risk ratio 
(RR) with confidence intervals (CI). Differences were 
considered to be significant upon p<0.05. Statistical 
analysis was performed with the use of the applica-
tion program “Statistica 6.0”.
Example of electrophoregram showing the 
results of PRSS1 gene restriction is presented on 
the fig. 1.
Figure 1. Electrophoretic detection of amplificated 
products by PCR restriction analysis in 1.5% agarose gel. 
Electrophoregram showing the results of PRSS1-gene 
restriction (№ 5 — Heterozygous to PRSS1 mutation)
Results and discussion
Different mutations of PRSS1, SPINK1, CFTR 
genes were detected in 18 (26.5%) patients and only 
in 4 (5.0%) healthy persons (p<0,001).
Spectrum of mutations identified in our patients 
was following: PRSS1 mutations were detected in 5 
(27.8%), PRSS1+SPINK1 — in 1 (5.6%), PRSS1+CFTR 
— in 2 (11.1%), CFTR — in 4 (22.1%), CFTR+SPINK1 
— in 1 (5.6%), SPINK1 — in 5 (27.8%) patients of all 
the patients with mutations. Only isolated cases of 
mutations in PRSS1, CFTR and SPINK1 genes were 
found in healthy persons (fig. 2).
Figure 2. Spectrum of PRSS1, SPINK1, CFTR genes 
mutations
Majority of the patients had a combination of 
active form of ADH gene (ADH1В*2) and active form 
of ALDH gene (ALDH2*1) — 38 (55.9%) patients. 
Combination of low-activity form of ADH gene 
(ADH1В*1) and active form of ALDH gene (ALDH2*1) 
was detected in 14 (20.6%) patients. Combination 
of low-activity form of ADH gene (ADH1В*1) and 
low-activity form of ALDH gene (ALDH2*2) — in 10 
(14.7%) patients. Combination of active form of ADH 
gene and low-activity form of ALDH gene was the 
rarest one (in 6 patients — 8.8%).
Distribution of ‘alcoholic cytochrome’ geno-
types -1293G/C CYP2E1 in patients with a combina-
tion of active form of ADH gene (ADH1В*2) and ac-
tive form of ALDH gene (ALDH2*1) corresponded to: 
G/G — 14.2%, G/C — 47.1%, C/C — 38.7%. Number 
of patients with allelic variant of G/C and C/C gene 
CYP2E1 -1293G/C increased in 1.3 and 3.5 times in 
comparison with control group.
We tried to draw a parallel between mutations 
and CP manifestations. In patients with PRSS1 gene 
mutations, indicators of fecal elastase at the level 
of less than 100 mcg/g, i.e. severe pancreatic insuf-
ficiency, were detected in 2.3 times as likely as in 
patients with ADH gene mutations — in 2.9 times 
more likely than in other patients.
In patients with SPINK1 mutations, calcification 
of the pancreas was determined in 2.1 times, and 
pseudocysts of the pancreas — in 2.5 times more 
likely than in other patients.
Conclusion
CP in Ukraine is being developed in more than 
a quarter of patients on the background of genetic 
predisposition. In our opinion, it’s a very high muta-
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tion rate. Peculiarities of the combinations of allelic 
variants of ADH, ALDH and CYP2E1 genes occur upon 
alcoholic CP. Therefore, it requires further studying 
and analysis.
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Summary
Chronic pancreatitis and its complications: surgical 
treatment 
Our study includes the results of surgical treatment of 412 
patients, during the perriod 1990-2012 in Surgical Clinic 
nr. 2. Operations of choice were following: pancreatojeju-
noanasthomosis (PJA), CDP, toracoscopic splanchnectomy. 
In the complicated cases with pancreatic pseudocyst (PP) 
– cystpancreatojejunoanasthomosis (CPJA) on the loop by 
Roux external drainage, ultrasound guided puncture of PP, 
toracoscopic splanchnectomy. PC complicated cases by 
obstructive jaundice – PJA with cholecysto-or-holedocho-
jejunoanasthomosis (CoCJA) on the splitted loop by Roux 
(Igr.), CPJA with CoCJA on the splitted loop by Roux II gr. 
Remained operations were not folowed by postoperative 
lethality.  




Xронический панкреатит и его осложнения: 
cовременное хирургическое лечение
В работе представлены результаты хирургического 
лечения 412 больных хроническим панкреатитом (ХР) 
и его осложнений. Были применены следующие хирур-
гические вмешательства: панкреатоеюноанастомоз 
на изолированной петле по Ру, панкреатодуоденаль-
ная резекция, торакоскопическая спланхникэкто-
мия. В случае псевдокист поджелудочной железы-
кистпанкреатоеюноанастомоз на изолированной 
петле по Ру, наружное дренирование. При хроническом 
панкреатите, осложнённом механической желтухой 
– панкреатоюноанастомоз и холецисто-холедохо) – 
еюноанастамоз на расщеплённой петле Ру. Ранней 
послеоперационной летальности не отмечалось.
Kлючевыe cлова: хронический панкреатит, псевдокиcта 
поджелудочнoй железы, мeхaничecкaя жeлтуxa. 
Introducere
Conform datelor OMS, pe parcursul ultimilor 20 
de ani mortalitatea prin pancreatită cronică (PC) și 
complicaţiile ei este în creștere continuă. Frecvenţa 
PC variază în populaţie de la 0,2% până la 0,6% la 100 
000 populaţie, înregistrându-se anual 7–10 cazuri 
noi de PC. Incidenţa în Europa diferă semnifcativ, se 
estimează la 8,2 cazuri noi la 100.000 de locuitori/an 
și variază de la 1 caz nou de PC la 100 000 de locuitori 
(Anglia) la 13 (Spania) și 23 (Elveţia). Prevalenţa PC 
în Europa este de 26,4 cazuri/an (în Franţa – 15,8 și 
în Spania – 18,3 la 100.000 de locuitori). PC și com-
plicaţiile ei rămân o afecţiune gravă și imprevizibilă, 
cu prognostic incert, chiar și în contextul unor te-
rapii ce se înscriu în linia protocoalelor terapeutice 
moderne [5].
Material și metode
Studiul prezintă rezultatele tratamentului 
chirurgical aplicat la 412 pacienţi cu PC și complica-
ţiile ei, desfășurat în perioada 1992-2012 în Clinica 
Chirurgie nr. 2. În lotul I au fost incluși pacienţi cu 
următoarele forme de PC: indurativă – 21 (15,24%) 
cazuri, pseudotumoroasă – 26 (29,52%) cazuri, cal-
culoasă – 68 (55,24%) cazuri. Lotul II a inclus cazurile 
de PC complicate cu pseudochist pancreatic (PP) – 
261 (92,6%) cazuri, icter mecanic – 45 (9,0%) cazuri, 
